Chronic Fatigue Syndrome Clinical Trial
Official title:
Acupuncture for the Sleep Disorder of Chronic Fatigue Syndrome
NCT number | NCT01534130 |
Other study ID # | 30801488 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | April 2011 |
Est. completion date | August 2012 |
Verified date | February 2020 |
Source | Chengdu University of Traditional Chinese Medicine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The investigators will conduct acupuncture for participants with chronic fatigue syndrome(CFS). Firstly the investigators aim to figure out the characteristic of sleep structure of CFS and the changes caused by acupuncture. Secondly the investigators seek to investigate the characteristic of sleep-wake rhythm, slow wave sleep(SWS)-rapid eye movement(REM)sleep rhythm, and REM sleep rhythm of CFS and the readjusting of acupuncture for it. Thirdly the investigators want to know the efficacy of acupuncture for relieving the fatigue, reducing accompanying symptoms and for improving the life quality of CFS.
Status | Completed |
Enrollment | 72 |
Est. completion date | August 2012 |
Est. primary completion date | August 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 50 Years |
Eligibility |
Inclusion Criteria: 1. Participants who meet the diagnosis criteria of CFS; 2. Clinically evaluated, exclude any disease that can explain the chronic fatigue; 3. The onset age of CFS is between 18 and 50 years old; 4. Have not taken any hypnotic, melatonin, or antidepressants within 45 days; 5. Willing to finish the whole observation period; 6. With written consent form signed by themselves. Exclusion Criteria: 1. Chronic fatigue caused by diseases such as internal diseases(for example, pulmonary emphysema, rheumatoid arthritis, etc.), mental illness(for example, any type of dementia paranoids, depression, etc.), some diseases that just onset or evaluated (for example, sleep deprivation, untreated diabetes, etc.), some diseases that need recovery gradually(for example, restless legs syndrome, lactation, etc.), morbid obesity; 2. Participants in other clinical research; 3. Pregnant women, lactating women. |
Country | Name | City | State |
---|---|---|---|
China | Chengdu university of Traditonal Chinese Medcine | Chengdu | Si Chuan Province |
Lead Sponsor | Collaborator |
---|---|
Chengdu University of Traditional Chinese Medicine | West China Hospital |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The sleep perception | The percentage of the ratio between the total sleep time perceived by the patient and the total sleep time obtained by PSG. | Change from baseline in sleep perception at 4 weeks | |
Secondary | The Pittsburgh Sleep Quality Index(PSQI) | Change from baseline in PSQI at 4 weeks | ||
Secondary | The Fatigue Severity Scale(FSS) | Change from baseline in FSS at 4 weeks | ||
Secondary | The Somatic and Psychological Health Report(SPHR) | Change from baseline in SPHR at 4 weeks | ||
Secondary | The Medical outcomes Study 36-Item Short-Form Health Survey questionnaire(SF-36) | Change from baseline in SF-36 at 4 weeks | ||
Secondary | Sleep-wake rhythm | Change from baseline in sleep-wake rhythm at 4 weeks | ||
Secondary | DSWS-REM sleep rhythm | Change from baseline in DSWS-REM sleep rhythm at 4 weeks | ||
Secondary | REM sleep rhythm | Change from baseline in REM sleep rhythm at 4 weeks | ||
Secondary | Sleep latency | Change from baseline in sleep latency at 4 weeks | ||
Secondary | Total sleep time | Change from baseline in total sleep time at 4 weeks | ||
Secondary | Sleep efficiency | Change from baseline in sleep efficiency at 4 weeks | ||
Secondary | Percentage of every sleep stage | Change from baseline in percentage of every sleep stage at 4 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05454683 -
Melatonin and Zinc Administration on Cardinal Symptoms in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
|
N/A | |
Completed |
NCT01686074 -
Motor Control in Chronic Fatigue Syndrome and Fibromyalgia
|
N/A | |
Completed |
NCT02075489 -
Acupressure for Pain Management and Fatigue Relief in Gulf War Veterans
|
N/A | |
Completed |
NCT01651754 -
Humoral and Cellular Immune Responses After Influenza Vaccination in Patients With Postcancer Fatigue and in Patients With Chronic Fatigue Syndrome
|
N/A | |
Completed |
NCT00540254 -
Behavioral Insomnia Therapy With Chronic Fatigue Syndrome
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT00071162 -
Genetics of Fibromyalgia
|
N/A | |
Withdrawn |
NCT04870476 -
Feasibility and Acceptability of the Internet-delivered Treatment "One Step at the Time" for Bodily Distress Syndrome
|
N/A | |
Completed |
NCT05730660 -
Quercetin Phytosome® Chronic Fatigue Syndrome
|
N/A | |
Recruiting |
NCT04542161 -
Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
|
Phase 2 | |
Recruiting |
NCT03807973 -
Tracking Peripheral Immune Cell Infiltration of the Brain in Central Inflammatory Disorders Using [Zr-89]Oxinate-4-labeled Leukocytes.
|
Phase 1 | |
Recruiting |
NCT05719493 -
Effectiveness and Health Benefits of a Nutritional, Chronobiological and Physical Exercise Intervention in Fibromyalgia and Chronic Fatigue Syndrome (SYNCHRONIZE +)
|
N/A | |
Recruiting |
NCT05967052 -
Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation
|
Phase 2 | |
Terminated |
NCT01730495 -
Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome
|
Phase 2 | |
Completed |
NCT01650636 -
Patient-Partner Stress Management Effects on Chronic Fatigue Syndrome Symptoms and Neuroimmune Process
|
N/A | |
Completed |
NCT01156909 -
B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome
|
Phase 2 | |
Completed |
NCT01046370 -
A Pilot Study of Amygdala Retraining Program in Patients With Chronic Fatigue Syndrome, Chronic Fatigue and Fibromyalgia
|
N/A | |
Completed |
NCT00100412 -
Hyporeactivity and Gulf War Illness
|
N/A | |
Recruiting |
NCT06128967 -
A Multicenter, Adaptive, Randomized, doublE-blinded, Placebo-controlled Study in Participants With Long COVID-19: The REVIVE Trial
|
Phase 3 | |
Completed |
NCT02669212 -
Myalgic Encephalomyelitis Chronic Fatigue at the National Institutes of Health
|
N/A | |
Not yet recruiting |
NCT06011135 -
Exploring Worry in CFS/ME
|